Management of Intermittent Headaches in Pediatric SLE with APS

Diagnostic Approach

Brain MRI with gadolinium-enhanced T1 sequences and diffusion-weighted imaging (DWI) must be performed to exclude stroke, hemorrhage, cerebral venous sinus thrombosis, or inflammatory lesions in patients with SLE and APS, as recommended by the European League Against Rheumatism 1
The presence of APS significantly increases risk for cerebral venous sinus thrombosis, which can present with intermittent headaches and vomiting in pediatric patients with SLE 1
Normal laboratory values do not exclude active CNS lupus, as neurological involvement can occur independently of systemic disease activity in patients with SLE and APS 2

Initiate therapeutic anticoagulation immediately with target INR 2.0-3.0 for venous thrombosis in APS, as recommended by the American College of Rheumatology 3
Consider pulse intravenous methylprednisolone if inflammatory component is present in patients with SLE and APS 1
Long-term anticoagulation is required for secondary prevention in APS-associated thrombosis, with a strength of evidence level of 1A 3

If imaging is negative, schedule regular follow-up every 3-6 months with assessment for new neurological symptoms in patients with SLE and APS, as recommended by the European League Against Rheumatism 5
Monitor antiphospholipid antibody levels intermittently in patients with SLE and APS 5
Ensure compliance with hydroxychloroquine, which improves outcomes by reducing disease flares in patients with SLE 5